Cited by 394Attention Deficit Hyperactivity DisorderNeurotransmitter Receptor Influence on BehaviorSchizophrenia research and treatment

The DOI matches its Crossref record; 162 of the 166 references it cites were found in a registry or an index.

The Dopamine Transporter and Attention-Deficit/Hyperactivity Disorder

Madras, Bertha K., Miller, Gregory M., Fischman, Alan J.·2005·Biological Psychiatry

DOI 10.1016/j.biopsych.2004.10.011

Open this paper in CoChat — free account

Abstract

The high incidence of attention-deficit/hyperactivity disorder (ADHD) and escalating use of ADHD medications present a compelling case for clarifying the pathophysiology of, and developing laboratory or radiologic tests for, ADHD. Currently, the majority of specific genes implicated in ADHD encode components of catecholamine signaling systems. Of these, the dopamine transporter (DAT) is a principal target of the most widely used antihyperactivity medications (amphetamine and methylphenidate); the DAT gene is associated with ADHD, and some studies have detected abnormal levels of the DAT in brain striatum of ADHD subjects. Medications for ADHD interfere with dopamine transport by brain-region- and drug-specific mechanisms, indirectly activating dopamine- and possibly norepinephrine-receptor subtypes that are implicated in enhancing attention and experiential salience. The most commonly used DAT-selective ADHD medications raise extracellular dopamine levels in DAT-rich brain regions. In brain regions expressing both the DAT and the norepinephrine transporter (NET), the relative contributions of dopamine and norepinephrine to ADHD pathophysiology and therapeutic response are obfuscated by the capacity of the NET to clear dopamine as well as norepinephrine. Thus, ADHD medications targeting DAT or NET might disperse dopamine widely and consign dopamine storage and release to regulation by noradrenergic, as well as dopaminergic neurons.

Integrity signals

Registry

Crossref · 10.1016/j.biopsych.2004.10.011

Cites

162 of 162 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Atomoxetine Increases Extracellular Levels of Norepinephrine and Dopamine in Prefrontal Cortex of Rat A Potential Mechanism for Efficacy in Attention Deficit/Hyperactivity Disorder
Bymaster, F. (2002) · Neuropsychopharmacology · doi:10.1016/s0893-133x(02)00346-9 · Cited by 1,123
Diagnosis and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents
Goldman, L. S. (1998) · JAMA · doi:10.1001/jama.279.14.1100 · Cited by 1,082
Association of attention-deficit disorder and the dopamine transporter gene.
Cook, E. H., Stein, M. A., Krasowski, M. D., Cox, N. J., Olkon, D. M., Kieffer, J. E., & LEVENTHAL, B. L. (1995) · PubMed · Cited by 995
Trace amines: Identification of a family of mammalian G protein-coupled receptors
Borowsky, B., Adham, N., JONES, K. A., Raddatz, R., Artymyshyn, R. P., Ogozalek, K. L., Durkin, M. M., Lakhlani, P. P., Bonini, J. A., Pathirana, S. M., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.151105198 · Cited by 912
Does stimulant therapy of attention-deficit/hyperactivity disorder beget later substance abuse? A meta-analytic review of the literature
Wilens, T. E., Faraone, S. V., Biederman, J., & Gunawardene, S. (2003) · Pediatrics · doi:10.1542/peds.111.1.179 · Cited by 872
Pharmacotherapy of Attention-Deficit Hyperactivity Disorder across the Life Cycle
SPENCER, T., BIEDERMAN, J., WILENS, T., HARDING, M., O'DONNELL, D., & GRIFFIN, S. (1996) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199604000-00008 · Cited by 830
Dopamine transporter density in patients with attention deficit hyperactivity disorder
Dougherty, D. D., Bonab, A. A., Spencer, T. J., Rauch, S. L., Madras, B. K., & Fischman, A. J. (1999) · The Lancet · doi:10.1016/s0140-6736(99)04030-1 · Cited by 684
Self-citation
Dopamine uptake through the norepinephrine transporter in brain regions with low levels of the dopamine transporter: evidence from knock-out mouse lines
Morón, J. A., Brockington, A., Wise, R. A., Rocha, B. A., & Hope, B. T. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-02-00389.2002 · Cited by 681
Atomoxetine in the Treatment of Children and Adolescents With Attention-Deficit/Hyperactivity Disorder: A Randomized, Placebo-Controlled, Dose-Response Study
Michelson, D., Faries, D., Wernicke, J., Kelsey, D., Kendrick, K., Sallee, F. R., Spencer, T., & the Atomoxetine ADHD Study Group (2001) · Pediatrics · doi:10.1542/peds.108.5.e83 · Cited by 666
Amphetamine, 3,4-Methylenedioxymethamphetamine, Lysergic Acid Diethylamide, and Metabolites of the Catecholamine Neurotransmitters Are Agonists of a Rat Trace Amine Receptor
Bunzow, J. R., Sonders, M. S., Arttamangkul, S., Harrison, L. M., Zhang, G., Quigley, D. I., Darland, T., Suchland, K. L., Pasumamula, S., Kennedy, J. L., et al. (2001) · Molecular Pharmacology · doi:10.1124/mol.60.6.1181 · Cited by 651
Cloning and Expression of a Cocaine-Sensitive Rat Dopamine Transporter
Kilty, J. E., Lorang, D., & Amara, S. (1991) · Science · doi:10.1126/science.1948035 · Cited by 597
The dopamine transporter: immunochemical characterization and localization in brain
Ciliax, B. J., Heilman, C. J., Demchyshyn, L. L., Pristupa, Z. B., Ince, E., Hersch, S. M., Niznik, H. B., & Levey, A. I. (1995) · Journal of Neuroscience · doi:10.1523/jneurosci.15-03-01714.1995 · Cited by 589
Cortical abnormalities in children and adolescents with attention-deficit hyperactivity disorder
Sowell, E. R., Thompson, P. M., Welcome, S. E., Henkenius, A. L., Toga, A. W., & Peterson, B. S. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14842-8 · Cited by 567
Genotype Influences In Vivo Dopamine Transporter Availability in Human Striatum
Heinz, A. (2000) · Neuropsychopharmacology · doi:10.1016/s0893-133x(99)00099-8 · Cited by 538
Increased striatal dopamine transporter in adult patients with attention deficit hyperactivity disorder: effects of methylphenidate as measured by single photon emission computed tomography
Krause, K.-H., Dresel, S. H., Krause, J., Kung, H. F., & Tatsch, K. (2000) · Neuroscience Letters · doi:10.1016/s0304-3940(00)01040-5 · Cited by 521
Attention-deficit/hyperactivity disorder (adhd) as a noradrenergic disorder
Biederman, J., & Spencer, T. J. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00192-4 · Cited by 515
Monoamine transporters and psychostimulant drugs.
Rothman, R., & Baumann, M. (2003) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2003.08.054 · Cited by 509
American Medical Association Council on Scientific Affairs
Goodman, C. S. (1988) · Cited by 496
Confirmation of association between attention deficit hyperactivity disorder and a dopamine transporter polymorphism.
Gill, M., Daly, G., Heron, S., Hawi, Z., & Fitzgerald, M. (1997) · Molecular Psychiatry · doi:10.1038/sj.mp.4000290 · Cited by 482
The dopamine transporter is localized to dendritic and axonal plasma membranes of nigrostriatal dopaminergic neurons
Nirenberg, M. J., Vaughan, R., Uhl, G. R., Kuhar, M. J., & Pickel, V. (1996) · Journal of Neuroscience · doi:10.1523/jneurosci.16-02-00436.1996 · Cited by 481
Is ADHD a risk factor for psychoactive substance use disorders? Findings from a four-year prospective follow-up study
BIEDERMAN, J., WILENS, T., MICK, E., FARAONE, S. V., WEBER, W., CURTIS, S., THORNELL, A., PFISTER, K., JETTON, J. G., & SORIANO, J. (1997) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199701000-00013 · Cited by 476
Studies on the distinction between uptake inhibition and release of [3H]dopamine in rat brain tissue slices
Heikkila, R. E., Orlansky, H., & Cohen, G. (1975) · Biochemical Pharmacology · doi:10.1016/0006-2952(75)90152-5 · Cited by 468
Prospective Study of Tobacco Smoking and Substance Dependencies Among Samples of ADHD and Non-ADHD Participants
Lambert, N. M., & Hartsough, C. S. (1998) · Journal of Learning Disabilities · doi:10.1177/002221949803100603 · Cited by 465
Association and linkage of the dopamine transporter gene and attention-deficit hyperactivity disorder in children: Heterogeneity owing to diagnostic subtype and severity
Waldman, I. D., Rowe, D. C., Abramowitz, A., Kozel, S. T., Mohr, J. H., Sherman, S. L., Cleveland, H. H., Sanders, M. L., Gard, J. M. C., & Stever, C. (1998) · The American Journal of Human Genetics · doi:10.1086/302132 · Cited by 462
Multiple Ionic Conductances of the Human Dopamine Transporter: The Actions of Dopamine and Psychostimulants
Sonders, M. S., Zhu, S.-J., Zahniser, N. R., Kavanaugh, M. P., & Amara, S. G. (1997) · Journal of Neuroscience · doi:10.1523/jneurosci.17-03-00960.1997 · Cited by 446
Catecholamines in Attention-Deficit Hyperactivity Disorder: Current Perspectives
Pliszka, S. R., McCracken, J. T., & Maas, J. W. (1996) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199603000-00006 · Cited by 436
The VNTR polymorphism of the human dopamine transporter (DAT1) gene affects gene expression
Fuke, S., Suo, S., Takahashi, N., Koike, H., Sasagawa, N., & Ishiura, S. (2001) · The Pharmacogenomics Journal · doi:10.1038/sj.tpj.6500026 · Cited by 415
Blockade of the Noradrenaline Carrier Increases Extracellular Dopamine Concentrations in the Prefrontal Cortex: Evidence that Dopamine Is Taken up In Vivo by Noradrenergic Terminals
Carboni, E., Tanda, G., Frau, R., & Chiara, G. D. (1990) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1990.tb04599.x · Cited by 412
Amphetamine-induced loss of human dopamine transporter activity: An internalization-dependent and cocaine-sensitive mechanism
Saunders, C., Ferrer, J. V., Shi, L., Chen, J., Merrill, G. A., Lamb, M. E., Leeb-Lundberg, L. M. F., Carvelli, L., Javitch, J. A., & Galli, A. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.110035297 · Cited by 410
Monoamine Transporters: From Genes to Behavior
Gainetdinov, R. R., & Caron, M. G. (2003) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.43.050802.112309 · Cited by 398
Amphetamine and other psychostimulants reduce pH gradients in midbrain dopaminergic neurons and chromaffin granules: a mechanism of action
Sulzer, D., & Rayport, S. (1990) · Neuron · doi:10.1016/0896-6273(90)90339-h · Cited by 389
A review of the biological bases of ADHD: What have we learned from imaging studies?
Durston, S. (2003) · Mental Retardation and Developmental Disabilities Research Reviews · doi:10.1002/mrdd.10079 · Cited by 388
Dopamine can be released by two mechanisms differentially affected by the dopamine transport inhibitor nomifensine.
Raiteri, M., Cerrito, F., Cervoni, A. M., & Levi, G. (1979) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)31548-x · Cited by 383
Stable expression of biogenic amine transporters reveals differences in inhibitor sensitivity, kinetics, and ion dependence.
Gu, H., Wall, S. C., & Rudnick, G. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)37256-3 · Cited by 379
Mapping susceptibility loci in attention deficit hyperactivity disorder: preferential transmission of parental alleles at DAT1, DBH and DRD5 to affected children
Daly, G., Hawi, Z., Fitzgerald, M., & Gill, M. (1999) · Molecular Psychiatry · doi:10.1038/sj.mp.4000510 · Cited by 377
DAncing past the DAT at a DA synapse
Cragg, S. J., & Rice, M. E. (2004) · Trends in Neurosciences · doi:10.1016/j.tins.2004.03.011 · Cited by 373
Attention-deficit/hyperactivity disorder: a life-span perspective.
Biederman, J. (1998) · PubMed · Cited by 361
Mechanism of action of methylphenidate: Insights from PET imaging studies
Volkow, N. D., Fowler, J. S., Wang, G., Ding, Y., & Gatley, S. J. (2002) · Journal of Attention Disorders · doi:10.1177/070674370200601s05 · Cited by 353
Regulated Trafficking of the Human Dopamine Transporter
Daniels, G. M., & Amara, S. G. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.50.35794 · Cited by 352
Dopamine transporter immunoreactivity in monkey cerebral cortex: regional, laminar, and ultrastructural localization
Lewis, D. A., Melchitzky, D. S., Sesack, S. R., Whitehead, R. E., Auh, S., & Sampson, A. (2001) · Journal of Comparative Neurology · doi:10.1002/cne.1092 · Cited by 352
Neurobiology of Attention Deficit Disorder With Hyperactivity: Where Have We Come in 50 Years?
Zametkin, A. J., & Rapoport, J. L. (1987) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-198709000-00011 · Cited by 348
Functional Interaction between Monoamine Plasma Membrane Transporters and the Synaptic PDZ Domain–Containing Protein PICK1
Torres, G. E., Yao, W.-D., Mohn, A. R., Quan, H., Kim, K.-M., Levey, A. I., Staudinger, J. L., & Caron, M. G. (2001) · Neuron · doi:10.1016/s0896-6273(01)00267-7 · Cited by 344
Expression of the dopamine transporter gene is regulated by the 3′ UTR VNTR: Evidence from brain and lymphocytes using quantitative RT-PCR
Mill, J., Asherson, P., Browes, C., D'Souza, U., & Craig, I. (2002) · American Journal of Medical Genetics · doi:10.1002/ajmg.b.10948 · Cited by 341
Delineation of discrete domains for substrate, cocaine, and tricyclic antidepressant interactions using chimeric dopamine-norepinephrine transporters.
Bruno Giros, A., Wang, Y. M., Suter, S. E., McLeskey, S. B., Pifl, C., & Caron, M. G. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)33961-3 · Cited by 322
Relationship between blockade of dopamine transporters by oral methylphenidate and the increases in extracellular dopamine: therapeutic implications
Volkow, N. D., Wang, G., Fowler, J. S., Logan, J., Franceschi, D., Maynard, L., Ding, Y., Gatley, S. J., Gifford, A., Zhu, W., et al. (2002) · Synapse · doi:10.1002/syn.10038 · Cited by 321
Striatal dopamine transporters and cognitive functioning in healthy men and women
Mozley, L. H., Gur, R. C., Mozley, P. D., & Gur, R. E. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.9.1492 · Cited by 314
Methylphenidate and dextroamphetamine treatments of hyperactivity: Are there true nonresponders?
Elia, J., Borcherding, B. G., Rapoport, J. L., & Keysor, C. S. (1991) · Psychiatry Research · doi:10.1016/0165-1781(91)90126-a · Cited by 294
Subcellular localization and molecular topology of the dopamine transporter in the striatum and substantia nigra
Hersch, S. M., Yi, H. L., Heilman, C. J., Edwards, R. H., & Levey, A. I. (1997) · The Journal of Comparative Neurology · doi:10.1002/(sici)1096-9861(19971117)388:2 · Cited by 290
Role of dopamine transporter genotype and maternal prenatal smoking in childhood hyperactive-impulsive, inattentive, and oppositional behaviors
Kahn, R. S., Khoury, J. C., Nichols, W. C., & Lanphear, B. P. (2003) · The Journal of Pediatrics · doi:10.1016/s0022-3476(03)00208-7 · Cited by 290
Oligomerization and Trafficking of the Human Dopamine Transporter
Torres, G. E., Carneiro, A. M. D., Seamans, K., Fiorentini, C., Sweeney, A., Yao, W., & Caron, M. G. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m201926200 · Cited by 278
Attention deficit hyperactivity disorder: binding of [99mTc]TRODAT-1 to the dopamine transporter before and after methylphenidate treatment
Dresel, S., Krause, J., Krause, K.-H., LaFougere, C., Brinkbäumer, K., Kung, H. F., Hahn, K., & Tatsch, K. (2000) · European Journal of Nuclear Medicine · doi:10.1007/s002590000330 · Cited by 278
Prediction of Dopamine Transporter Binding Availability by Genotype: A Preliminary Report
Jacobsen, L. K., Staley, J. K., Zoghbi, S. S., Seibyl, J. P., Kosten, T. R., Innis, R. B., & Gelernter, J. E. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.10.1700 · Cited by 277
Abnormal dopamine uptake sites in postmortem striatum from patients with tourette's syndrome
Singer, H. S., Hahn, I., & Moran, T. H. (1991) · Annals of Neurology · doi:10.1002/ana.410300408 · Cited by 273
ATTENTION-DEFICIT/HYPERACTIVITY DISORDER AND COMORBIDITY
Spencer, T. J., Biederman, J., & Wilens, T. (1999) · Pediatric Clinics of North America · doi:10.1016/s0031-3955(05)70163-2 · Cited by 271
Methylphenidate treatment during pre- and periadolescence alters behavioral responses to emotional stimuli at adulthood
Bolaños, C. A., Barrot, M., Berton, O., Wallace-Black, D., & Nestler, E. J. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(03)00570-5 · Cited by 266
Attention-deficit/hyperactivity disorder and the substance use disorders: the nature of the relationship, subtypes at risk, and treatment issues
Wilens, T. E. (2004) · Psychiatric Clinics of North America · doi:10.1016/s0193-953x(03)00113-8 · Cited by 264
The Dopamine Transporter Constitutively Internalizes and Recycles in a Protein Kinase C-regulated Manner in Stably Transfected PC12 Cell Lines
Loder, M. K., & Melikian, H. E. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m301845200 · Cited by 255
Anti-hyperactivity medication: methylphenidate and amphetamine
Seeman, P., & Madras, B. K. (1998) · Molecular Psychiatry · doi:10.1038/sj.mp.4000421 · Cited by 252
Self-citation
Cocaine receptors labeled by [3H]2 beta-carbomethoxy-3 beta-(4-fluorophenyl)tropane.
Madras, B. K., Spealman, R. D., Fahey, M. A., Neumeyer, J. L., Saha, J. K., & Milius, R. A. (1989) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09647-6 · Cited by 250
Self-citation
Development of a New Once-a-Day Formulation of Methylphenidate for the Treatment of Attention-deficit/Hyperactivity Disorder: Proof-of-Concept and Proof-of-Product Studies
Swanson, J., Gupta, S., Lam, A., Shoulson, I., Lerner, M., Modi, N., Lindemulder, E., & Wigal, S. (2003) · Archives of General Psychiatry · doi:10.1001/archpsyc.60.2.204 · Cited by 248
Enduring behavioral effects of early exposure to methylphenidate in rats
Carlezon, W. A., Mague, S. D., & Andersen, S. L. (2003) · Biological Psychiatry · doi:10.1016/j.biopsych.2003.08.020 · Cited by 248
Association of the Dopamine Transporter Gene (DAT1) With Poor Methylphenidate Response
Winsberg, B. G., & Comings, D. E. (1999) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199912000-00006 · Cited by 242
Dopamine transporter–mediated conductances increase excitability of midbrain dopamine neurons
Ingram, S., Prasad, B. M., & Amara, S. (2002) · Nature Neuroscience · doi:10.1038/nn920 · Cited by 239
Polymorphisms in the 3′-untranslated region of human and monkey dopamine transporter genes affect reporter gene expression
Miller, G. M., & Madras, B. K. (2002) · Molecular Psychiatry · doi:10.1038/sj.mp.4000921 · Cited by 233
Self-citation
Stimulant drugs and ADHD : basic and clinical neuroscience
Solanto, M. V., Arnsten, A. F. T., & Castellanos, F. X. (2001) · Cited by 223
[123I]beta-CIT SPECT imaging of striatal dopamine transporter binding in Tourette's disorder
Malison, R. T., McDougle, C. J., van Dyck, C. H., Scahill, L. D., Baldwin, R. M., Seibyl, J. P., Price, L. H., Leckman, J. F., & Innis, R. B. (1995) · American Journal of Psychiatry · doi:10.1176/ajp.152.9.1359 · Cited by 223
A human dopamine transporter cDNA predicts reduced glycosylation, displays a novel repetitive element and provides racially-dimorphic TaqI RFLPs
Vandenbergh, D. J., Persico, A. M., & Uhl, G. R. (1992) · Molecular Brain Research · doi:10.1016/0169-328x(92)90165-8 · Cited by 222
Characteristics of Drug Interactions with Recombinant Biogenic Amine Transporters Expressed in the Same Cell Type
Eshleman, A. J., Carmolli, M., Cumbay, M. G., Martens, C. R., Neve, K. A., & Janowsky, A. J. (1999) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38214-x · Cited by 219
Acute tolerance to methylphenidate in the treatment of attention deficit hyperactivity disorder in children*
Swanson, J., Gupta, S., Guinta, D., Flynn, D., Agler, D., Lerner, M., Williams, L., Shoulson, I., & Wigal, S. (1999) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(99)70038-x · Cited by 216
Dendrodendritic Inhibition Through Reversal of Dopamine Transport
Falkenburger, B. H., Barstow, K. L., & Mintz, I. M. (2001) · Science · doi:10.1126/science.1060645 · Cited by 214
Cocaine Increases Dopamine Uptake and Cell Surface Expression of Dopamine Transporters
Daws, L. C., Callaghan, P. D., Morón, J. A., Kahlig, K. M., Shippenberg, T. S., Javitch, J. A., & Galli, A. (2002) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2002.6384 · Cited by 208
The dopamine transporter gene (SLC6A3) variable number of tandem repeats domain enhances transcription in dopamine neurons
Michelhaugh, S. K., FISKERSTRAND, C. E., Lovejoy, E. A., Bannon, M. J., & Quinn, J. P. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00647.x · Cited by 199
Current concepts on the neurobiology of Attention-Deficit/Hyperactivity Disorder
Biederman, J., & Faraone, S. V. (2002) · Journal of Attention Disorders · doi:10.1177/070674370200601s03 · Cited by 194
A new inhibitor of norepinephrine uptake devoid of affinity for receptors in rat brain.
Wong, D. T., Threlkeld, P. G., Best, K. L., & Bymaster, F. P. (1982) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)33153-8 · Cited by 194
Oligomerization of Dopamine Transporters Visualized in Living Cells by Fluorescence Resonance Energy Transfer Microscopy
Sorkina, T., Doolen, S., Galperin, E., Zahniser, N. R., & Sorkin, A. D. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m210652200 · Cited by 192
Dopamine transporter density in the basal ganglia assessed with [123I]IPT SPET in children with attention deficit hyperactivity disorder
Cheon, K.-A. A., Ryu, Y. H., Kim, Y.-K., Namkoong, K., Kim, C., & Lee, J. E. (2003) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-002-1047-3 · Cited by 189
The Role of N-Glycosylation in Function and Surface Trafficking of the Human Dopamine Transporter
Li, L., Chen, N., Ramamoorthy, S., Chi, L., Cui, X., Wang, L. C., & Reith, M. E. A. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m311972200 · Cited by 189
The dopamine transporter and neuroimaging in attention deficit hyperactivity disorder
Krause, K.-H., Dresel, S. H. J., Krause, J., la Fougère, C., & Ackenheil, M. (2003) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2003.08.012 · Cited by 185
The Variable Number of Tandem Repeats Polymorphism of the Dopamine Transporter Gene Is Not Associated with Significant Change in Dopamine Transporter Phenotype in Humans
Martinez, D. (2001) · Neuropsychopharmacology · doi:10.1016/s0893-133x(00)00216-5 · Cited by 182
Neurochemical and behavioral differences between d-methamphetamine and d-amphetamine in rats
Shoblock, J. R., Sullivan, E. B., Maisonneuve, I. M., & Glick, S. D. (2003) · Psychopharmacology · doi:10.1007/s00213-002-1288-7 · Cited by 181
Dynamic regulation of the dopamine transporter
Mortensen, O. V., & Amara, S. G. (2003) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2003.08.066 · Cited by 181
Stimulant Drugs and ADHD: Basic and Clinical Neuroscience
Durant, N. A. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.11.1959-a · Cited by 179
$alpha;-Synuclein regulation of the dopaminergic transporter: a possible role in the pathogenesis of Parkinson's disease
Sidhu, A., Wersinger, C., & Vernier, P. (2004) · FEBS Letters · doi:10.1016/j.febslet.2004.03.063 · Cited by 175
Serum and brain concentrations of methylphenidate: implications for use and abuse
Swanson, J. M., & Volkow, N. D. (2003) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2003.08.013 · Cited by 172
Cocaine Induction of Dopamine Transporter Trafficking to the Plasma Membrane
Little, K. Y., Elmer, L. W., Zhong, H., Scheys, J. O., & Zhang, L. (2002) · Molecular Pharmacology · doi:10.1124/mol.61.2.436 · Cited by 172
Inability to N-glycosylate the human norepinephrine transporter reduces protein stability, surface trafficking, and transport activity but not ligand recognition.
Melikian, H. E., Ramamoorthy, S., Tate, C. G., & Blakely, R. (1996) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09218-1 · Cited by 171
Attention‐deficit hyperactivity disorder: A study of association with both the dopamine transporter gene and the dopamine D4 receptor gene
Roman, T., Schmitz, M. D., Polanczyk, G. V., Eizirik, M., Rohde, L. A., & Hutz, M. H. (2001) · American Journal of Medical Genetics · doi:10.1002/ajmg.1408 · Cited by 171
Functional Effects of the DAT1 Polymorphism on EEG Measures in ADHD
Loo, S. K., SPECTER, E., Smolen, A., Hopfer, C. J., Teale, P. D., & Reite, M. L. (2003) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/01.chi.0000046890.27264.88 · Cited by 167
Haplotype study of three polymorphisms at the dopamine transporter locus confirm linkage to attention-deficit/hyperactivity disorder
Barr, C. L., Xu, C., Kroft, J., Feng, Y., Wigg, K. G., Zai, G. C., Tannock, R., Schachar, R. J., MALONE, M. A., Roberts, W., et al. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(00)01053-2 · Cited by 167
Trace amine receptors as targets for novel therapeutics: legend, myth and fact
Branchek, T. A., & Blackburn, T. P. (2003) · Current Opinion in Pharmacology · doi:10.1016/s1471-4892(02)00028-0 · Cited by 165
Association study of a dopamine transporter polymorphism and attention deficit hyperactivity disorder in UK and Turkish samples
Curran, S. R., Mill, J. S., Tahir, E., Kent, L., Richards, S., Gould, A., Huckett, L., Sharp, J., Batten, C., Fernando, S., et al. (2001) · Molecular Psychiatry · doi:10.1038/sj.mp.4000914 · Cited by 164
Dopamine genes and attention-deficit hyperactivity disorder: a review
DiMaio, S., Grizenko, N., & Joober, R. (2003) · Journal of Psychiatry and Neuroscience · doi:10.1139/jpn.0303 · Cited by 153
Association of the 480 bp DAT1 allele with methylphenidate response in a sample of Irish children with ADHD
Kirley, A., Lowe, N., Hawi, Z., Mullins, C., Daly, G., Waldman, I. D., McCarron, M., O'Donnell, D., Fitzgerald, M., & Gill, M. (2003) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.20071 · Cited by 151
A family-based and case-control association study of the dopamine D4 receptor gene and dopamine transporter gene in attention deficit hyperactivity disorder
Holmes, J., Payton, A., Barrett, J. H., Hever, T., Fitzpatrick, H., Trumper, A., Harrington, R., McGuffin, P., Owen, M. J., Ollier, W., et al. (2000) · Molecular Psychiatry · doi:10.1038/sj.mp.4000751 · Cited by 147
Early Methylphenidate Administration to Young Rats Causes a Persistent Reduction in the Density of Striatal Dopamine Transporters
Moll, G. H., Hause, S., Rüther, E., Rothenberger, A., & Huether, G. (2001) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/104454601750143366 · Cited by 147
Unaltered Dopamine Transporter Availability in Adult Attention Deficit Hyperactivity Disorder
van Dyck, C. H., Quinlan, D. M., Cretella, L. M., Staley, J. K., Malison, R. T., Baldwin, R. M., Seibyl, J. P., & Innis, R. B. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.2.309 · Cited by 139
Differential effects of psychostimulants and related agents on dopaminergic and serotonergic transporter function
Fleckenstein, A. E., Haughey, H. M., Metzger, R. R., Kokoshka, J. M., Riddle, E. L., Hanson, J. E., Gibb, J. W., & Hanson, G. R. (1999) · European Journal of Pharmacology · doi:10.1016/s0014-2999(99)00588-9 · Cited by 136
Attention-Deficit/Hyperactivity Disorder and Substance Use: Symptom Pattern and Drug Choice
Clure, C. L., Brady, K. T., Saladin, M. E., Johnson, D. E., Waid, R., & Rittenbury, M. (1999) · The American Journal of Drug and Alcohol Abuse · doi:10.1081/ada-100101871 · Cited by 135
Dopamine and nicotinic receptor binding and the levels of dopamine and homovanillic acid in human brain related to tobacco use
Court, J. A., Lloyd, S., Thomas, N., Piggott, M. A., Marshall, E. F., Morris, C. M., Lamb, H., Perry, R. H., Johnson, M., & Perry, E. K. (1998) · Neuroscience · doi:10.1016/s0306-4522(98)00088-8 · Cited by 135
Regulation of the Vesicular Monoamine Transporter-2: A Novel Mechanism for Cocaine and Other Psychostimulants
Brown, J. M., Hanson, G. R., & Fleckenstein, A. E. (2001) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38814-7 · Cited by 135
Dopamine transporter gene and response to methylphenidate in attention-deficit/hyperactivity disorder
Roman, T., Szobot, C. M., Martins, S., Biederman, J., Rohde, L. A., & Hutz, M. H. (2002) · Pharmacogenetics · doi:10.1097/00008571-200208000-00011 · Cited by 133
Cerebrospinal Fluid Homovanillic Acid Predicts Behavioral Response to Stimulants in 45 Boys with Attention Deficit/Hyperactivity Disorder
Castellanos, F. X., Elia, J., Kruesi, M. J. P., Marsh, W., Gulotta, C. S., Potter, W. Z., Ritchie, G. F., Hamburger, S. D., & Rapoport, J. L. (1996) · Neuropsychopharmacology · doi:10.1016/0893-133x(95)00077-q · Cited by 129
Methylphenidate elevates resting dopamine which lowers the impulse-triggered release of dopamine: a hypothesis
Seeman, P. M., & Madras, B. K. (2002) · Behavioural Brain Research · doi:10.1016/s0166-4328(01)00435-1 · Cited by 125
Self-citation
Methylphenidate Down-Regulates the Dopamine Receptor and Transporter System in Children with Attention Deficit Hyperkinetic Disorder (ADHD)
Vles, J. S. H., FERON, F. J. M., Hendriksen, J. G. M., Jolles, J., van Kroonenburgh, M. J. P. G., & Weber, W. E. J. (2003) · Neuropediatrics · doi:10.1055/s-2003-39602 · Cited by 122
Methylphenidate Redistributes Vesicular Monoamine Transporter-2: Role of Dopamine Receptors
Sandoval, V., Riddle, E. L., Hanson, G. R., & Fleckenstein, A. E. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-19-08705.2002 · Cited by 121
Assessment of muscarinic receptor concentrations in aging and Alzheimer disease with [11C]NMPB and PET
Zubieta, J., Koeppe, R. A., Frey, K. A., Kilbourn, M. R., Mangner, T. J., Foster, N. L., & Kuhl, D. E. (2001) · Synapse · doi:10.1002/1098-2396(20010315)39:4 · Cited by 118
Self-citation
Inhibitory Effects of Nitric Oxide on the Uptake of [3H]Dopamine and [3H]Glutamate by Striatal Synaptosomes
Lónárt, G., & Johnson, K. M. (1994) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1994.63062108.x · Cited by 115
Genetic heterogeneity in catatonic schizophrenia: A family study
Beckmann, H., Franzek, E., & Stöber, G. (1996) · American Journal of Medical Genetics · doi:10.1002/(sici)1096-8628(19960531)67:3 · Cited by 110
Structure‐activity relations for the inhibition of catecholamine uptake into synaptosomes from noradrenaline and dopaminergic neurones in rat brain homogenates
Horn, A. S. (1973) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1973.tb08331.x · Cited by 109
Rapid regulation of dopamine transporter function by substrates, blockers and presynaptic receptor ligands
Gulley, J. M., & Zahniser, N. R. (2003) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2003.08.064 · Cited by 107
Repeated methylphenidate treatment in adolescent rats alters gene regulation in the striatum
Brandon, C. L., & Steiner, H. (2003) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2003.02892.x · Cited by 105
Greater Availability of Brain Dopamine Transporters in Major Depression Shown by [99mTc]TRODAT-1 SPECT Imaging
Brunswick, D. J., Amsterdam, J. D., Mozley, P. D., & Newberg, A. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.10.1836 · Cited by 104
Psychoactive drugs in the immature organism
Kornetsky, C. H. (1970) · Psychopharmacology · doi:10.1007/bf00402703 · Cited by 100
The dopamine transporter gene is associated with attention deficit hyperactivity disorder in a Taiwanese sample
CHEN, C.-K., Chen, S.-L., Mill, J. S., Huang, Y.-S., Lin, S.-K., Curran, S. R., Purcell, S., Sham, P. C., & Asherson, P. J. (2003) · Molecular Psychiatry · doi:10.1038/sj.mp.4001238 · Cited by 98
Association of Norepinephrine Transporter Gene With Methylphenidate Response
Yang, L., Wang, Y., Li, J., & Faraone, S. V. (2004) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/01.chi.0000131134.63368.46 · Cited by 97
The dopamine transporter: relevance to attention deficit hyperactivity disorder (ADHD)
Madras, B. K., Miller, G. M., & Fischman, A. J. (2002) · Behavioural Brain Research · doi:10.1016/s0166-4328(01)00439-9 · Cited by 97
Self-citation
Intracellular Ca2+ Regulates Amphetamine-Induced Dopamine Efflux and Currents Mediated by the Human Dopamine Transporter
Gnegy, M. E., Khoshbouei, H., Berg, K. A., Javitch, J. A., Clarke, W. P., Zhang, M., & Galli, A. (2004) · Molecular Pharmacology · doi:10.1124/mol.66.1.137 · Cited by 96
Dopamine transporter binding in Gilles de la Tourette syndrome
Müller-Vahl, K. R., Berding, G., Brücke, T., Kolbe, H., Meyer, G. J., Hundeshagen, H., Dengler, R., Knapp, W. H., & Emrich, H. M. (2000) · Journal of Neurology · doi:10.1007/pl00007806 · Cited by 95
Super-stereotypy I: Enhancement of a complex movement sequence by systemic dopamine D1 agonists
Berridge, K. C., & Aldridge, J. W. (2000) · Synapse · doi:10.1002/1098-2396(20000901)37:3 · Cited by 93
Autoradiographic localization of cocaine binding sites by [3H]CFT ([3H]WIN 35,428) in the monkey brain
Canfield, D. R., Spealman, R. D., Kaufman, M. J., & Madras, B. K. (1990) · Synapse · doi:10.1002/syn.890060211 · Cited by 91
Self-citation
Alpha2‐adrenoceptor mediated co‐release of dopamine and noradrenaline from noradrenergic neurons in the cerebral cortex
Devoto, P., Flore, G., Pira, L., Longu, G., & Gessa, G. L. (2004) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.02239.x · Cited by 88
Drug Therapy for Adults with Attention-Deficit Hyperactivity Disorder
Wilens, T. E. (2003) · Drugs · doi:10.2165/00003495-200363220-00002 · Cited by 86
Functional expression of the norepinephrine transporter in cultured rat astrocytes
Inazu, M., Takeda, H., & Matsumiya, T. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01514.x · Cited by 86
Phenylethylaminergic mechanisms in attention-deficit disorder
Baker, G. B., Bornstein, R. A., Rouget, A. C., Ashton, S., Muyden, J. C. V., & Coutts, R. T. (1991) · Biological Psychiatry · doi:10.1016/0006-3223(91)90207-3 · Cited by 84
Novel treatments for attention-deficit/hyperactivity disorder in children.
Spencer, T. J., Biederman, J., Wilens, T. E., & Faraone, S. V. (2002) · PubMed · Cited by 83
Stimulant drug treatment of hyperactivity: Biochemical correlates
Elia, J., Borcherding, B. G., Potter, W. Z., Mefford, I. N., Rapoport, J. L., & Keysor, C. S. (1990) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.1990.118 · Cited by 83
No association of the dopamine transporter gene 3′ VNTR polymorphism with ADHD subtypes in a population sample of twins
Todd, R. D., Jong, Y.-J. I., Lobos, E. A., Reich, W., Heath, A. C., & Neuman, R. J. (2001) · American Journal of Medical Genetics · doi:10.1002/ajmg.1611 · Cited by 77
No evidence of linkage or linkage disequilibrium between DAT1 and attention deficit hyperactivity disorder in a large sample
Palmer, C. G. S., Bailey, J. N., Ramsey, C., Cantwell, D. P., Sinsheimer, J. S., Del’Homme, M., McGough, J. J., Woodward, J. A., Asarnow, R. F., Asarnow, J. R., et al. (1999) · Psychiatric Genetics · doi:10.1097/00041444-199909000-00009 · Cited by 76
Inhibition of [3H]dopamine accumulation in rat striatal synaptosomes by psychotropic drugs
Hyttel, J. (1978) · Biochemical Pharmacology · doi:10.1016/0006-2952(78)90159-4 · Cited by 72
Chronic methylphenidate alters locomotor activity and dopamine transporters differently from cocaine
Izenwasser, S., Coy, A. E., Ladenheim, B., Loeloff, R. J., Cadet, J. L., & French, D. (1999) · European Journal of Pharmacology · doi:10.1016/s0014-2999(99)00274-5 · Cited by 69
Regulation of the functional activity of the human dopamine transporter by the arachidonic acid pathway
Zhang, L., & Reith, M. E. A. (1996) · European Journal of Pharmacology · doi:10.1016/s0014-2999(96)00646-2 · Cited by 65
Inhibition of mouse brain monoamine oxidase by (+)-amphetaminein vivo
Green, A. L., & Hait, M. A. S. E. (1978) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1978.tb13223.x · Cited by 64
Differences between d -methamphetamine and d -amphetamine in rats: working memory, tolerance, and extinction
Shoblock, J. R., Maisonneuve, I. M., & Glick, S. D. (2003) · Psychopharmacology · doi:10.1007/s00213-003-1522-y · Cited by 64
Non-stimulant treatment for Attention-Deficit/Hyperactivity Disorder
Spencer, T. J., & Biederman, J. (2002) · Journal of Attention Disorders · doi:10.1177/070674370200601s13 · Cited by 62
Variation of variable number of tandem repeat sequences in the 3′-untranslated region of primate dopamine transporter genes that affects reporter gene expression
Inoue‐Murayama, M., Adachi, S., Mishima, N., Mitani, H., Takenaka, O., Terao, K., Hayasaka, I., Ito, S., & Murayama, Y. (2002) · Neuroscience Letters · doi:10.1016/s0304-3940(02)01125-4 · Cited by 61
Absence of tolerance to the behavioral effects of methylphenidate in hyperactive and inattentive children
Safer, D. J., & Allen, R. P. (1989) · The Journal of Pediatrics · doi:10.1016/s0022-3476(89)80759-0 · Cited by 59
Drugs used in the treatment of attention-deficit/hyperactivity disorder affect postsynaptic firing rate and oscillation without preferential dopamine autoreceptor action
Ruskin, D. N., Bergstrom, D. A., Shenker, A., Freeman, L. E., Baek, D., & Walters, J. R. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(00)00987-2 · Cited by 57
No change in striatal dopamine re-uptake site density in psychotropic drug naive and in currently treated Tourette’s disorder patients: a [123I]-β-CIT SPECT-study
Stamenkovic, M., Schindler, S. D., Asenbaum, S., Neumeister, A., Willeit, M., Willinger, U., de Zwaan, M., Riederer, F., Aschauer, H. N., & Kasper, S. (2001) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(00)00134-6 · Cited by 52
Increased urine phenylethylamine after methylphenidate treatment in children with ADHD
Kusaga, A., Yamashita, Y., Koeda, T., Hiratani, M., Kaneko, M., Yamada, S., & Matsuishi, T. (2002) · Annals of Neurology · doi:10.1002/ana.10302 · Cited by 52
Determination of Residues in the Norepinephrine Transporter That Are Critical for Tricyclic Antidepressant Affinity
Roubert, C., Cox, P. J., Brüss, M., Hamon, M., Bönisch, H., & Bruno Giros, A. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m009798200 · Cited by 49
Daily methylphenidate administration attenuates c-fos expression in the striatum of prepubertal rats
Chase, T. D., Brown, R. E., CARREY, N. J., & Wilkinson, M. (2003) · Neuroreport · doi:10.1097/00001756-200304150-00022 · Cited by 48
A Pharmacokinetic/Pharmacodynamic Study Comparing a Single Morning Dose of Adderall to Twice-Daily Dosing in Children With ADHD
Greenhill, L. L., SWANSON, J. M., Steinhoff, K., FRIED, J., Posner, K., Lerner, M., Wigal, S. B., Clausen, S., Zhang, Y., & Tulloch, S. J. (2003) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-200310000-00015 · Cited by 47
Ethanol potentiates the function of the human dopamine transporter expressed inXenopusoocytes
Mayfield, R. D., Maiya, R., Keller, D., & Zahniser, N. R. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00656.x · Cited by 45
Phenylethylamine Excretion in Attention Deficit Disorder
Zametkin, A. J., Karoum, F., Rapoport, J. L., Brown, G. L., & Wyatt, R. J. (1984) · Journal of the American Academy of Child Psychiatry · doi:10.1016/s0002-7138(09)60509-4 · Cited by 44
Single nucleotide polymorphisms distinguish multiple dopamine transporter alleles in primates: implications for association with attention deficit hyperactivity disorder and other neuropsychiatric disorders
Miller, G. M., Garza, R. D. L., Novak, M. A., & Madras, B. K. (2000) · Molecular Psychiatry · doi:10.1038/sj.mp.4000809 · Cited by 44
Self-citation
The human dopamine transporter gene: the 5′-flanking region reveals five diallelic polymorphic sites in a Caucasian population sample
Rubie, C., Schmidt, F., Knapp, M., Sprandel, J., Wiegand, C., Meyer, J., Jungkunz, G., Riederer, P. F., & Stöber, G. (2001) · Neuroscience Letters · doi:10.1016/s0304-3940(00)01685-2 · Cited by 42
Novel halogenated analogs of tomoxetine that are potent and selective inhibitors of norepinephrine uptake in brain
Gehlert, D. R., Schober, D. A., Hemrick-Luecke, S. K., Krushinski, J. H., Howbert, J. J., Robertson, D. W., Fuller, R. W., & Wong, D. T. (1995) · Neurochemistry International · doi:10.1016/0197-0186(94)00113-9 · Cited by 37
Dopamine transporter synthesis and degradation rate in rat striatum and nucleus accumbens using RTI-76
Kimmel, H. L., Carroll, F. I., & Kuhar, M. J. (2000) · Neuropharmacology · doi:10.1016/s0028-3908(99)00160-4 · Cited by 37
Altropane, a SPECT or PET imaging probe for dopamine neurons: I. dopamine transporter binding in primate brain
Madras, B. K., Meltzer, P. C., Liang, A. Y., Elmaleh, D. R., Babich, J. W., & Fischman, A. J. (1998) · Synapse · doi:10.1002/(sici)1098-2396(199806)29:2 · Cited by 37
Self-citation
Effects of d-amphetamine on urinary metabolites of dopamine and norepinephrine in hyperactive boys
Shekim, W. O., Javaid, J. I., Dekirmenjian, H., Chapel, J. L., & Davis, J. M. (1982) · American Journal of Psychiatry · doi:10.1176/ajp.139.4.485 · Cited by 37
Differential Interactions of Desipramine with Amphetamine and Methamphetamine: Evidence that Amphetamine Releases Dopamine from Noradrenergic Neurons in the Medial Prefrontal Cortex
Shoblock, J. R., Maisonneuve, I. M., & Glick, S. D. (2004) · Neurochemical Research · doi:10.1023/b:nere.0000026409.76261.f3 · Cited by 35
Alterations in Vesicular Dopamine Uptake Contribute to Tolerance to the Neurotoxic Effects of Methamphetamine
Johnson‐Davis, K. L., Truong, J. G., Fleckenstein, A. E., & Wilkins, D. G. (2004) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.062695 · Cited by 32
Catecholamine uptake sites in mouse brain: distribution determined by quantitative [3H]mazindol autoradiography
Donnan, G. A., Kaczmarczyk, S. J., McKenzie, J. S., Kalnins, R. M., Chilco, P. J., & Mendelsohn, F. A. O. (1989) · Brain Research · doi:10.1016/0006-8993(89)91598-9 · Cited by 31
Dopamine transporter‐dependent induction of C‐Fos in HEK cells
Yatin, S. M., Miller, G. M., Norton, C., & Madras, B. K. (2002) · Synapse · doi:10.1002/syn.10084 · Cited by 27
Self-citation
Attention deficit and hyperactivity disorder: review of genetic association studies.
Galili‐Weisstub, E., & Segman, R. H. (2003) · PubMed · Cited by 27
Dopamine Transporter Genotype Influences the Attention Deficit in Korean Boys with ADHD
Oh, K., Shin, D. W., Oh, G. T., & Noh, K. S. (2003) · Yonsei Medical Journal · doi:10.3349/ymj.2003.44.5.787 · Cited by 24
Treatment of ADHD When Tolerance to Methylphenidate Develops
Ross, D. C., Fischhoff, J., & Davenport, B. (2002) · Psychiatric Services · doi:10.1176/appi.ps.53.1.102 · Cited by 23
Efficacy of Adderall and Methylphenidate in Attention Deficit Hyperactivity Disorder: A Reanalysis Using Drug–Placebo and Drug–Drug Response Curve Methodology
Faraone, S. V., Pliszka, S. R., Olvera, R. L., Skolnik, R., & Biederman, J. (2001) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/104454601750284081 · Cited by 21
[Association studies of dopamine D4 receptor gene and dopamine transporter gene polymorphisms in Han Chinese patients with attention deficit hyperactivity disorder].
Qian, Q., Wang, Y., Li, J., Yang, L., Wang, B., & Zhou, R. (2003) · PubMed · Cited by 20
Störungen der Aufmerksamkeit und Aktivität (ADHS)
Schwemmle, C., Schwemmle, U., & Ptok, M. (2007) · HNO · doi:10.1007/s00106-007-1564-2 · Cited by 19
Attention deficit hyperactivity disorder
Tucker, S. M. (1999) · Journal of the Royal Society of Medicine · doi:10.1177/014107689909200501 · Cited by 18
Urinary phenethylamine response to d-amphetamine in 12 boys with attention deficit disorder
Zametkin, A. J., Brown, G. L., Karoum, F., Rapoport, J., Langer, D. H., Chuang, L., & Wyatt, R. J. (1984) · American Journal of Psychiatry · doi:10.1176/ajp.141.9.1055 · Cited by 12

Research works printed but not linked: 5

Barkley, 2001, vol. 9
Brown, 2001, Regulation of the vesicular monoamine transporter-2, J Pharmacol Exp Ther, 296, 762
DiMaio, 2003, Dopamine genes and attention-deficit hyperactivity disorder, J Psychiatry Neurosci, 28, 27
Galili-Weisstub, 2003, Attention deficit and hyperactivity disorder, Isr J Psychiatry Relat Sci, 40, 57
Goulet, 2000, Chronic methylphenidate treatment suppresses activity in more active juvenile monkeys and induces sleep disturbances, Soc Neurosci Abstracts, 26, 2177

Sorted by citations

Dopamine: Functions, Signaling, and Association with Neurological Diseases
Klein, M. O., Battagello, D. S., Cardoso, A. R., Hauser, D. N., Bittencourt, J. C., & Correa, R. G. (2019) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-018-0632-3 · Cited by 1,073
Neurobiology of ADHD
Tripp, G., & Wickens, J. R. (2009) · Neuropharmacology · doi:10.1016/j.neuropharm.2009.07.026 · Cited by 492
Measured Gene-Environment Interactions in Psychopathology: Concepts, Research Strategies, and Implications for Research, Intervention, and Public Understanding of Genetics
Moffitt, T. E., Caspi, A., & Rutter, M. (2006) · Perspectives on Psychological Science · doi:10.1111/j.1745-6916.2006.00002.x · Cited by 389
Developmental phenotypes and causal pathways in attention deficit/hyperactivity disorder: potential targets for early intervention?
Sonuga‐Barke, E. J. S., & Halperin, J. M. (2010) · Journal of Child Psychology and Psychiatry · doi:10.1111/j.1469-7610.2009.02195.x · Cited by 320
Reward circuitry dysfunction in psychiatric and neurodevelopmental disorders and genetic syndromes: animal models and clinical findings
Dichter, G. S., Damiano, C. A., & Allen, J. A. (2012) · Journal of Neurodevelopmental Disorders · doi:10.1186/1866-1955-4-19 · Cited by 299

See all 394

Authors: Madras, B. K., Miller, G. M., & Fischman, A. J.
Affiliations: Harvard University (US)
Massachusetts General Hospital (US)
Corresponding author: Madras, Bertha K.
ORCID: Madras, Bertha K.
Miller, Gregory M.
Venue: Biological Psychiatry
Publisher: Elsevier BV
Published: 2005-06
Volume: 57
Issue: 11
Pages: 1397-1409
ISSN: 0006-3223 (ISSN-L)
DOI: 10.1016/j.biopsych.2004.10.011
OpenAlex: W2011083427
Cited by: 393
References: 166
Citations by year: 2026: 10 · 2025: 20 · 2024: 9 · 2023: 13 · 2022: 11 · 2021: 12 · 2020: 18 · 2019: 10 · 2018: 11 · 2017: 11 · 2016: 14 · 2015: 15 · 2014: 23 · 2013: 16 · 2012: 27
FWCI: 4.54
Type: journal article
Language: en
Open access: closed
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: Biological Psychiatry (publishedVersion)
PubMed (publishedVersion)
Funders: National Institute on Drug Abuse (DA 06303, R01DA011558, K05DA015305, DA15305, DA 11558)
National Center for Research Resources (RR00 168)
Topics: Health Sciences › Medicine › Psychiatry and Mental health › Attention Deficit Hyperactivity Disorder
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
Keywords: dopamine transporter, attention deficit hyperactivity disorder, ADHD pathophysiology, catecholamine signaling, norepinephrine transporter, amphetamine, methylphenidate, striatum, dopamine, norepinephrine, ADHD medication, genetic susceptibility
MeSH terms: Adaptation, Physiological, Central Nervous System Stimulants, Animals, Attention Deficit Disorder with Hyperactivity, Diagnostic Imaging, Humans, Membrane Glycoproteins, Mutation, Nerve Tissue Proteins, Genetic Variation, Membrane Transport Proteins, Dopamine Plasma Membrane Transport Proteins, Vesicular Biogenic Amine Transport Proteins

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

The Dopamine Transporter and Attention-Deficit/Hyperactivity Disorder

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks